Skip to main content
Top

Seminars in Immunopathology

Issue 3/2008

NOX Enzymes in Immuno-Inflammatory Pathologies

Content (14 Articles)

Introduction

NOX enzymes in immuno-inflammatory pathologies

Karl-Heinz Krause, Karen Bedard

Review

Nox enzymes in immune cells

William M. Nauseef

Review

Genetics and immunopathology of chronic granulomatous disease

Marie José Stasia, Xing Jun Li

Review

Role of Nox2 in elimination of microorganisms

Balázs Rada, Csilla Hably, András Meczner, Csaba Timár, Gergely Lakatos, Péter Enyedi, Erzsébet Ligeti

Review

Hyperinflammation in chronic granulomatous disease and anti-inflammatory role of the phagocyte NADPH oxidase

Michela G. Schäppi, Vincent Jaquet, Dominique C. Belli, Karl-Heinz Krause

Review

The NADPH oxidase NOX2 plays a role in periodontal pathologies

Catherine Giannopoulou, Karl-Heinz Krause, Frauke Müller

Review

NOX enzymes and Toll-like receptor signaling

Eric Ogier-Denis, Sanae Ben Mkaddem, Alain Vandewalle

Review

NOX enzymes and diabetic complications

Tomoko Kakehi, Chihiro Yabe-Nishimura

Review

Nox enzymes and oxidative stress in the immunopathology of the gastrointestinal tract

Kazuhito Rokutan, Tsukasa Kawahara, Yuki Kuwano, Kumiko Tominaga, Keisei Nishida, Shigetada Teshima-Kondo

Review

Oxidative stress and the pathogenesis of scleroderma: the Murrell’s hypothesis revisited

Armando Gabrielli, Silvia Svegliati, Gianluca Moroncini, Giovanni Pomponio, Mariarosaria Santillo, Enrico V. Avvedimento

Review

NOX enzymes as novel targets for drug development

J. David Lambeth, Karl-Heinz Krause, Robert A. Clark

Latest issues

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine